Tarsus Pharmaceuticals Inc (TARS) — Defensive Interval Ratio
Tarsus Pharmaceuticals Inc (TARS) has a Defensive Interval Ratio of 713 days as of June 2026. Defensive assets of $343.40 Million (cash $-, short-term investments $245.09 Million, receivables $98.31 Million) cover 713 days of daily cash needs of $481.52K/day.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Tarsus Pharmaceuticals Inc Defensive Interval Ratio (2018–2025)
This chart shows how Tarsus Pharmaceuticals Inc's Defensive Interval Ratio has evolved across 8 annual periods from 2018 to 2025. As of June 2026, the ratio stands at 713 days, meaning defensive assets of $343.40 Million can fund 713 days of operations without new revenue. For the complete balance sheet picture, see TARS total assets.
Annual Defensive Interval Ratio for Tarsus Pharmaceuticals Inc (2018–2025)
The table below presents the year-by-year Defensive Interval Ratio for Tarsus Pharmaceuticals Inc from 2018 to 2025, covering 8 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See TARS working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 863 days | $320.74 Million | $371.77K/day | $- | $233.63 Million | ▼ -245 days |
| 2024 | 1108 days | $244.62 Million | $220.85K/day | $- | $196.56 Million | ▲ +908 days |
| 2023 | 200 days | $20.21 Million | $101.19K/day | $- | $2.50 Million | ▼ -3324 days |
| 2022 | 3524 days | $148.95 Million | $42.27K/day | $- | $145.37 Million | ▲ +3505 days |
| 2021 | 18 days | $575.00K | $31.45K/day | $- | $483.00K | ▲ +17 days |
| 2020 | 1 days | $20.00K | $14.76K/day | $- | $0.00 | ▼ -15 days |
| 2019 | 16 days | $36.00K | $2.24K/day | $- | $- | ▲ +8 days |
| 2018 | 8 days | $4.00K | $490.41/day | $- | $- | — |